NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $65.43M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.21M
Average 0.18M
Returns on capital
NeurAxis, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-229.5%
avg 106.7%
ROIC
-204.7%
avg 117.4%
ROA
-121.8%
avg -670.1%
Analysis
ROA is currently the strongest return metric at -121.8% versus its period average of -670.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Brian Carrico | President, Chief Executive Officer & Director | USD 547.6K | 44 | — | — |
Timothy Robert Henrichs | Chief Financial Officer | USD 489.42K | 53 | 9.53K | 0.08% |
Thomas Carrico | Chief Regulatory Officer and Compliance & Privacy Officer | USD 400.58K | 69 | — | — |
Adrian Miranda | Senior Vice President of Science & Technology and Chief Medical Officer | USD 399.07K | 56 | 0 | <0.01% |
Craig Blanchard | Chief Commercial Officer | — | — | — | — |
Trisha Baumgardt | Vice President of Marketing | — | — | — | — |
Ryan Kuhlman | Vice President of Sales | — | — | — | — |
Behnam Shamsian | Investor Relations | — | — | — | — |
Christopher Robin Brown | Founder, Director of Innovation & Director | — | 72 | 792.84K | 6.40% |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 8, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
9
$1.43M
Sells
0
$0.00
Net Transaction Value
+$1.43M
Net buying
Most Active
Carrico Brian Allen
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 8, 26Oct 8, 2026 | Carrico Brian Allen Direct | Buy | $1.3K$1,297.12 |
| Oct 8, 26Oct 8, 2026 | Carrico Thomas Joeseph Direct | Buy | $1.6K$1,587.52 |
| Oct 8, 26Oct 8, 2026 | Henrichs Timothy Robert Direct | Buy | $9.4K$9,375.08 |
| Apr 1, 26Apr 1, 2026 | Carrico Brian Allen Direct | Buy | $15.8K$15,797.60 |
| Apr 1, 26Apr 1, 2026 | Carrico Thomas Joeseph Direct | Buy | $1.3K$1,307.32 |
| Apr 1, 26Apr 1, 2026 | Henrichs Timothy Robert Direct | Buy | $14.9K$14,882.28 |
| Feb 12, 26Feb 12, 2026 | Hannasch Brian Direct | Buy | $196.8K$196,800.00 |
| Feb 11, 26Feb 11, 2026 | Hannasch Brian Direct | Buy | $186K$186,000.00 |
| Dec 23, 25Dec 23, 2025 | Aharon Gil Indirect | Buy | $1M$1,007,205.76 |
Summary
Insiders reported 9 buys worth $1.43M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $1.43M. Carrico Brian Allen was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +10.0% | +103.3% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +10.0% over three years. Forward estimates point to Revenue at +103.3% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does NeurAxis, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about NRXS's management, answered from reported figures.
Who manages NRXS?
NeurAxis, Inc. (NRXS) lists 9 active executives. The top listed executive is Adrian Miranda, Senior Vice President of Science & Technology and Chief Medical Officer.
Are NRXS insiders buying or selling?
Recent insider activity shows net buying of $2.92M.
Continue the stock analysis
Jump to another research area for this company.